Re: Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)2254-2255
Number of pages2
JournalJournal of Urology
Volume186
Issue number6
DOIs
StatePublished - Dec 2011
Externally publishedYes

ASJC Scopus subject areas

  • Urology

Cite this